In the laboratory animal study, ursolic acid, the active compound in holy basil, combined with radiation was more effective at inducing skin cancer cell death and inhibiting
new tumors from forming than radiation alone.
Not exact matches
A
new study, conducted by the U.S. National Toxicology Program, found that rats consistently exposed to radiofrequency radiation
from cellphones were more likely to develop malignant
tumors in the brain and heart.
Immunotherapy differs
from more traditional cancer treatments, such as surgery (cutting malignant cells out of the body), chemotherapy and radiation (poisoning the deadly mutants), and even the
newer, more precise molecular drugs that attempt to jam the protein signals that tell
tumor cells to keep dividing and conquering.
It has already invested in some companies that graduated
from the Labs incubator, including Modern Meadow, a
New Jersey — based startup that's biofabricating leather without the need for animals, and 3Scan, a company that enables 3D analysis of
tumors and organs.
Chicago, GenomeWeb — A
new study by researchers
from Memorial Sloan Kettering Cancer Center has demonstrated the predictive power of an AR - V7 protein expression test using Epic Sciences» non-EPCAM-based circulating
tumor cell detection platform, which could help guide treatment decisions for men with metastatic castration - resistant prostate cancer.
At a time when individual tribulations seem to have grown with increasingly difficult economic times, it's no wonder that the ballroom was filled with at least 200 people
from as far as
New York,
New Jersey and Virginia, many with testimonies of being cured of ailments
from chronic sinus issues and financial woes, to smoking cessation and the disappearance of
tumors.
In 2010, researchers
from the University of Michigan Comprehensive Cancer Center published a study in the journal Clinical Cancer Research showing that sulforaphane had the ability to kill breast cancer stem cells in mice and in lab cultures, and it also prevented the growth of
new tumor cells.
It was confirmed June 29 and I love the keto diet because not only is it helping me heal chemo side - effects
from 2000/2001, I can feel a
new freedom in my abdomen, I know it's clearing
tumors away.
After John's diagnosis, when Isabella was in third grade, the family relocated
from North Carolina to Michigan, then later, on to
New York and Minnesota as John underwent surgeries to remove
tumors, implant pain pumps and reconstruct parts of his skull.
NEW YORK (CBSNewYork / AP)-- The New York assemblyman accused of asking young female staffers to massage him, touch his cancerous tumors and join him in hotel rooms said Saturday he will resign rather than possibly be expelled from the Legislature amid sexual harassment allegatio
NEW YORK (CBSNewYork / AP)-- The
New York assemblyman accused of asking young female staffers to massage him, touch his cancerous tumors and join him in hotel rooms said Saturday he will resign rather than possibly be expelled from the Legislature amid sexual harassment allegatio
New York assemblyman accused of asking young female staffers to massage him, touch his cancerous
tumors and join him in hotel rooms said Saturday he will resign rather than possibly be expelled
from the Legislature amid sexual harassment allegations.
These discoveries were made by oncologist Dr. Michael Kühn
from the Department of Internal Medicine III, which is a part of the University Center for
Tumor Diseases (UCT) at the Mainz University Medical Center, in a collaborative effort with researchers
from the Memorial Sloan - Kettering Cancer Center in
New York and Harvard University in Boston.
Unlike conventional chemotherapies and radiation that indiscriminately eradicate fast - growing tissues and ravage people's bodies with side effects,
new therapies specifically target
tumors using tailored cells
from individual patients.
A
new study by Dana - Farber Cancer Institute scientists suggests it may be possible to prevent
tumors from recurring and to eradicate metastatic growths by implanting a gel containing immunotherapy during surgical removal of a
tumor.
Isaacson's surgical team is helping pioneer a
new minimally invasive procedure that extracts vertigo - inducing
tumors from the inner ear without having to remove a large piece of skull.
Moreover, the combo prevented any
new breast
tumors from appearing.
Researchers at the University of Cincinnati (UC) College of Medicine have shown that a
new targeted treatment could benefit patients with certain pancreatic
tumors by preventing spread of the cancer and protecting their heart
from damage — a direct result of the
tumor.
«This gives us novel and exciting
new therapeutic options to pursue based on results
from drug screenings of primary
tumor samples
from patients.»
Comparing the metastasized
tumors with the original breast
tumors, the researchers were surprised to learn that multiple, slightly genetically different cells
from the original site had broken away together and established the
new tumors.
The initial experiments made use of cancer cells that Quiñones - Hinojosa and his team removed
from willing patients and grew in the laboratory until they formed little spheres of cells, termed oncospheres, likely to be the most resistant to chemotherapy and radiation, and capable of creating
new tumors.
In a
new study, a team found that injecting mice with tiny magnets and cranking up the heat eliminated
tumors from the animals» bodies with no apparent side effects.
Now a team of researchers in China has developed a
new microfluidic chip that can quickly and efficiently segregate and capture live circulating
tumor cells (CTCs)
from a patient's blood, with potential applications for cancer screenings and treatment assessments.
A team under Professor Scheffler, consisting of researchers
from the Bonn University Hospital, the Life & Brain Center, The German Consortium for Translational Cancer Research, Tufts University Boston / Massachusetts, and other institutes in the USA, has now developed a
new method that is expected to combat such complex brain
tumors better.
A randomized phase III trial finding that a
new monoclonal antibody, elotuzumab, added to standard therapy, extended the duration of remission for patients with relapsed multiple myeloma by about five months Findings
from two phase III studies showing that children with Wilms
tumor who have a specific chromosomal abnormality do better with a more intensive, augmented chemotherapy regimen
Biopsied
tumor tissue
from all 60
new patients was fixed in formalin and embedded in paraffin so that TMEM sites in the tissue could be counted.
It is well established that melanoma cells can spread through the blood to accumulate and form
new tumors (metastases) in other parts of the body away
from the original
tumor.
A
new investigation of more than 48,000 stored
tumor samples finds evidence of a key deficiency in a repair mechanism designed to keep DNA
from being mutated and causing cancer.
The
new «
tumor in a dish» method begins by taking the cancerous tissue removed during surgery or biopsy, cutting it up into small pieces and putting them in a special collagen gel that maintains them as «organoids» that retain the three - dimensional structure of the original
tumor and include supporting cells
from the
tumor's environment.
Bone metastases happen when cancer cells travel
from the primary
tumor site to the bone, establishing a
new cancer location.
The
new study overcame this limitation by selectively dissecting cancer cells
from pieces of
tumor tissue.
Lee's study results, which appear in the July 16, 2015 issue of Nature Communications, revealed
new understanding about how 14 -3-3 sigma — a cell cycle «controller» - regulates cancer metabolic programming, thus protecting healthy cells
from turning into
tumor - producing factories.
In the past few years, Vogelstein and Kinzler have shifted away
from discovering
new cancer genes to a less glamorous pursuit: using genetic tests to detect common
tumors as early as possible, when they are easiest to cure.
Researchers
from Northwestern Medicine and Ann & Robert H. Lurie Children's Hospital of Chicago have revealed
new insight into how the most deadly pediatric brain
tumor, diffuse intrinsic pontine glioma (DIPG), may develop.
Orchestrating a successful immune attack against
tumors has proven difficult so far, but a
new study
from MIT suggests that such therapies could be improved by simultaneously activating both arms of the immune system.
New research
from George Vasmatzis, Ph.D., of the Department of Laboratory Medicine and Pathology at Mayo Clinic, finds liquid biopsies
from blood tests and DNA sequencing can detect a return of ovarian cancer long before a
tumor reappears.
This is critical if we are to develop
new treatments to prevent epilepsy
from developing after a head injury, stroke, or brain
tumor.»
Metastasis is the process in which cells
from a primary
tumor break - off, enter the blood stream and create
new tumors elsewhere in the body.
Study leader Fausto J. Rodriguez, M.D., associate professor of pathology at the Johns Hopkins University School of Medicine and member of the Johns Hopkins Kimmel Cancer Center, says the
new study sought to sort out what makes the more aggressive NF1 - related
tumors genetically different
from low grade
tumors and normal, healthy cells.
This allows cancer cells to break off
from tumors, spread throughout the body (in blood or other fluid) and form
new tumors at distant sites — a process called metastasis.
Siva Vanapalli, an associate professor in the Department of Chemical Engineering, at Texas Tech University, recently received two grants
from the Cancer Prevention and Research Institute of Texas (CPRIT) to study the movement of
tumor cells throughout the body and
new methods of detecting cancer cells.
A
new guideline
from the U.S. Multi-Society Task Force on Colorectal Cancer recommends genetic testing of
tumors for all newly diagnosed colorectal cancer patients.
In a development that could lead to a
new generation of drugs to precisely treat a range of diseases, scientists
from the Florida campus of The Scripps Research Institute (TSRI) have for the first time designed a drug candidate that decreases the growth of
tumor cells in animal models in one of the hardest to treat cancers — triple negative breast cancer.
Insights into how cells move through the body could lead to innovative techniques to stop cancer cells
from spreading and causing secondary
tumors, according to
new UCL research.
Research
from Rutgers Cancer Institute of
New Jersey examining difficult to treat cancer
tumors through genomic profiling shows that
tumors with alterations in a signaling pathway responsible for cell regulation may respond to targeted therapy regardless of where the
tumor originated in the body.
In a
new study, Yale Cancer Center researchers identified a novel genetic defect that prevents brain
tumor cells
from repairing damaged DNA.
The results
from our
new study suggest that entinostat may enhance the anti-tumor efficacy of PD - 1 targeted therapy through MDSC targeting, potentially providing an effective combination treatment approach for patients with solid
tumors, including lung and renal cell carcinoma.»
Research
from Rutgers Cancer Institute of
New Jersey shows that the «first in human» series of vaccine injections given directly into a pancreatic cancer
tumor is not only well tolerated, but also suggests an «encouraging» period of stable disease.
In several steps using a
new strategy and a novel drug, Burkhard Becher's team
from the Institute of Experimental Immunology at the University of Zurich has now succeeded in doing exactly this in the case of glioblastoma, one of the most dangerous brain
tumors.
One goal of drug designers has been to prevent
tumors from making
new blood vessels, a process known as angiogenesis.
Improving the understanding of these genetic changes in these diseases, can point to
new directions for diagnosis and treatment, including a way to potentially differentiate aggressive
tumors from those that are not life threatening.
In order to enhance the diagnosis of CNS
tumors, a team led by Professor Stefan Pfister, KiTZ director and department head of «Pediatric Neurooncology» at the DKFZ, in collaboration with colleagues
from the Neuropathology Department at Heidelberg University Hospital led by Professor Andreas von Deimling, have developed a
new computer - based method.